Question 1

What are the potential benefits and risks of participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Safety and Efficacy Study of AC-3933 in Adults With Mild to Moderate Alzheimer's Disease clinical trial (NCT00359944). Contact the study team or your healthcare provider for specific answers.

Question 2

How does AC-3933 compare to my current treatment options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Safety and Efficacy Study of AC-3933 in Adults With Mild to Moderate Alzheimer's Disease clinical trial (NCT00359944). Contact the study team or your healthcare provider for specific answers.

Question 3

What will happen during the study visits, and how often will they occur?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Safety and Efficacy Study of AC-3933 in Adults With Mild to Moderate Alzheimer's Disease clinical trial (NCT00359944). Contact the study team or your healthcare provider for specific answers.

Question 4

Are there any side effects I should be aware of while taking AC-3933?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Safety and Efficacy Study of AC-3933 in Adults With Mild to Moderate Alzheimer's Disease clinical trial (NCT00359944). Contact the study team or your healthcare provider for specific answers.

Question 5

How will my progress be monitored throughout the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Safety and Efficacy Study of AC-3933 in Adults With Mild to Moderate Alzheimer's Disease clinical trial (NCT00359944). Contact the study team or your healthcare provider for specific answers.

Question 6

What support will be available for me and my caregiver during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Safety and Efficacy Study of AC-3933 in Adults With Mild to Moderate Alzheimer's Disease clinical trial (NCT00359944). Contact the study team or your healthcare provider for specific answers.

What this study is about